Testing effectiveness (Phase 2)Study completedNCT01806675
What this trial is testing
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more
Sanjiv Sam Gambhir 25